Floatz logo

FTC-146

Sciatica

Stanford UniversitySmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Sciatica cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
University of Miami
Phase 4BBB
LIDOCAINE
C.L.A.Vleggeert-Lankamp
Phase 4BBB
NEPENTHE
Akdeniz University
Phase 4BB
Naproxen
Ostfold Hospital Trust
Phase 4BB
PREDNISONE TABLETS
Kaiser Permanente
Phase 3BB

View all 45 →

Same molecule, other indications

FTC-146 is also rated in:

Pediatric DisorderDormant
CC
Indicative ·
47 / 100
View asset →
Nociceptive PainDormant
CC
Indicative ·
47 / 100
View asset →
neuralgiaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →